Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers
A phase 2 trial of Temoporfin in Head and neck squamous cell carcinoma, run by University of Arkansas, recorded as terminated on the registry.
Overview
Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers is a phase 2 interventional study registered as NCT01415986 by University of Arkansas, with 1 participants recorded, started 2010-11 and due to reach its primary completion in 2011-08. Interventions recorded: Temoporfin, Medical diode laser emitting light at a wavelength of 652 nm. (Ceralas PDT 652, CeramOptec GmbH). Conditions recorded: Squamous Cell Carcinoma of the Head and Neck.
Linked to the drug Temoporfin because the registry names it among its interventions and Head and neck squamous cell carcinoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialFoscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma
Shares Temoporfin and the tag pipeline.
- TrialSafety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
Shares Temoporfin and the tag pipeline.
- TrialMIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialA Study of DM005 in Patients With Advanced Solid Tumors
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialA Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialIntratumoral N17350 in Advanced Solid Tumors
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialResponse Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
Shares Head and neck squamous cell carcinoma and the tag pipeline.
- TrialFID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
Shares Head and neck squamous cell carcinoma and the tag pipeline.